Legal & General Group
RLYB icon

Legal & General Group’s Rallybio RLYB Stock Holding History

Legal & General Group’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-368
Closed -$5.46K – 3493
2024
Q1 		$5.46K Hold
368
– – ﹤0.01% 3289
2023
Q4 		$7.04K Hold
368
– – ﹤0.01% 3279
2023
Q3 		$9.91K Hold
368
– – ﹤0.01% 3269
2023
Q2 		$16.7K Buy
368
+71
+24% +$3.48K ﹤0.01% 3184
2023
Q1 		$13.6K Hold
297
– – ﹤0.01% 3154
2022
Q4 		$15.5K Buy
297
+69
+30% +$4.07K ﹤0.01% 3200
2022
Q3 		$26K Buy
228
+10
+5% +$891 ﹤0.01% 3138
2022
Q2 		$13K Hold
218
– – ﹤0.01% 3338
2022
Q1 		$12K Buy
218
+135
+163% +$11.2K ﹤0.01% 3367
2021
Q4 		$6K Hold
83
– – ﹤0.01% 3537
2021
Q3 		$12K Buy
+83
New +$9.73K ﹤0.01% 3419

Other funds holding RLYB

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Legal & General Group's RLYB Position: Q2 2024 in Review

Legal & General Group sold out of Rallybio (RLYB) in Q2 2024, closing a stake of 368 shares — an estimated $5.46K sold.

Legal & General Group first reported a position in RLYB in Q3 2021 and held it in 11 quarters. The position peaked at $26K in Q3 2022. 66 funds tracked by Wall St. Rank hold RLYB as of Q2 2024.

  • Legal & General Group reported no remaining Rallybio position as of Q2 2024 after selling out during the quarter.
  • Legal & General Group sold 368 Rallybio shares in Q2 2024, an estimated $5.46K.
  • Legal & General Group first reported a position in Rallybio in Q3 2021 and held it in 11 quarters.
  • Legal & General Group's Rallybio position peaked at $26K in Q3 2022.
  • 66 funds tracked by Wall St. Rank held Rallybio as of Q2 2024.

Based on Legal & General Group's 13F filing for Q2 2024, filed 14 Aug 2024.